PCV33 A COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN FOUR EUROPEAN COUNTRIES
2019 ◽
Vol 8
(24)
◽
2003 ◽
Vol 03
(2)
◽
pp. 177-184
◽
2005 ◽
Vol 352
(13)
◽
pp. 1293-1304
◽